FDA issues quarterly list of drugs with potential safety concerns

08/29/2010 | Reuters

Roche Holding's breast cancer drug Herceptin and Sanofi-Aventis' heart drug Multaq are on the FDA's quarterly list of treatments being investigated for possible safety risks. The list also includes Pfizer's antibiotic Cleocin, Merck & Co.'s contraceptive Implanon and Novartis' cancer treatment Afinitor.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA